Clinical Trial Update: Tolerance Through Mixed Chimerism (Sip-Tego) [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial investigating tolerance through mixed chimerism in kidney transplant recipients (Sip-Tego) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: Tatsuo Kawai, MD, PhD | Conditions: Kidney Failure, Transplant Recipient (Kidney) | EARLY_Phase 1 | Status: RECRUITING